Uncategorized

Certain Lots of Taro-Zoledronic acid injection drug, used for osteoporosis and Paget’s disease, recalled due to potential presence of particulate matter

Posted on

Health Canada is advising Canadians that Taro Pharmaceuticals Inc. is recalling five lots of Taro-Zoledronic acid injection 5mg/100mL (DIN 02415100) because of the potential presence of particulate matter in the drug. Zoledronic acid is used to treat and prevent osteoporosis, as well as to treat Paget’s disease (i.e., a condition that causes bone deformities).

Uncategorized

Health Canada warns of the recall of several USB wall chargers due to shock, burn or fire hazards

Posted on

Health Canada recently tested a number of USB wall chargers intended for use with cell phones, tablets and other devices as part of a planned national compliance and enforcement project. The following certified and uncertified products were found to pose an unacceptable risk of electric shock, burn or fire, and are being recalled by industry. This table will be updated if and when new products are recalled.